Evidence map›Paper›PMID 32436348›Full record

ArticleInternational journal of experimental pathology2020

A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.

Melody T Tan, Jean G Wu, Juan Luis Callejas-Valera, Richard A Schwarz, Ann M Gillenwater, Rebecca R Richards-Kortum, Nadarajah Vigneswaran

Open access · greenAbstract readComparative Study
In one paragraph

Article in International journal of experimental pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Melody T TanDepartment of Bioengineering, Rice University, Houston, TX, USA.ORCID 0000-0001-9918-4062
Jean G WuDepartment of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, TX, USA.
Juan Luis Callejas-ValeraCancer Biology Research Center, Sanford Research, Sioux Falls, SD, USA.
Richard A SchwarzDepartment of Bioengineering, Rice University, Houston, TX, USA.
Ann M GillenwaterDepartment of Head and Neck Surgery, M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA.
Rebecca R Richards-KortumDepartment of Bioengineering, Rice University, Houston, TX, USA.
Nadarajah VigneswaranDepartment of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, TX, USA.
Rice University · USSanford Research · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
Optical Systems for In Vivo Molecular Imaging of CancerR01CA103830 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI RICHARDS-KORTUM, REBECCA R. · 2004 to 2015
$12.4M
(PQC2) Optical Hallmarks of Aggressive Clones Within Oral Field CancerizationR01CA185207 · NCI · RICE UNIVERSITY · PI GILLENWATER, ANN M, RICHARDS-KORTUM, REBECCA R. · 2014 to 2017
$2.6M
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cellsR01DE024392 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ANNAPRAGADA, ANANTH V, VIGNESWARAN, NADARAJAH · 2014 to 2017
$1.5M
NCI NIH HHS P30 CA016672NIH HHS R01 CA103830NIH HHS R01 CA185207NIH HHS R01 DE024392
6 · The paper itself

Abstract

Oral cancer causes significant global mortality and has a five-year survival rate of around 64%. Poor prognosis results from late-stage diagnosis, highlighting an important need to develop better approaches to detect oral premalignant lesions (OPLs) and identify which OPLs are at highest risk of progression to oral squamous cell carcinoma (OSCC). An appropriate animal model that reflects the genetic, histologic, immunologic, molecular and gross visual features of human OSCC would aid in the development and evaluation of early detection and risk assessment strategies. Here, we present an experimental PIK3CA + 4NQO transgenic mouse model of oral carcinogenesis that combines the PIK3CA oncogene mutation with oral exposure to the chemical carcinogen 4NQO, an alternate experimental transgenic mouse model with PIK3CA as well as E6 and E7 mutations, and an existing wild-type mouse model based on oral exposure to 4NQO alone. We compare changes in dorsal and ventral tongue gross visual appearance, histologic features and molecular biomarker expression over a time course of carcinogenesis. Both transgenic models exhibit cytological and architectural features of dysplasia that mimic human disease and exhibit slightly increased staining for Ki-67, a cell proliferation marker. The PIK3CA + 4NQO model additionally exhibits consistent lymphocytic infiltration, presents with prominent dorsal and ventral tongue tumours, and develops cancer quickly relative to the other models. Thus, the PIK3CA + 4NQO model recapitulates the multistep genetic model of human oral carcinogenesis and host immune response in carcinogen-induced tongue cancer, making it a useful resource for future OSCC studies.

Indexed as

MutationQuinolones4-Nitroquinoline-1-oxideAnimalsCell ProliferationCell Transformation, NeoplasticClass I Phosphatidylinositol 3-KinasesDisease Models, AnimalDisease ProgressionLymphocytesMice, Inbred CBAMice, TransgenicOncogene Proteins, ViralSquamous Cell Carcinoma of Head and NeckTime FactorsTongue Neoplasms4-Nitroquinoline-1-oxide4-nitroquinolone-1-oxideClass I Phosphatidylinositol 3-KinasesOncogene Proteins, ViralQuinolones4NQOcarcinogenesisoral premalignant lesionsoral squamous cell carcinomaPIK3CAtransgenic mouse model

Identifiers

PMID32436348
PMCPMC7306900
OpenAlexW3028328806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.